Our Purpose
Non-alcoholic steatohepatitis (NASH) or metabolic dysfunction associated steatohepatitis (MASH) is increasingly recognized as one of the most common causes of liver disease worldwide. In order to understand the global impact of this disease, The Global NASH Council was created to include renowned experts from different regions of the world with interest in NASH/MASH to collaborate and exchange their views about NASH. The Global NASH Council includes 312 members from 65 countries from all the continents across the globe. Members of the Council carry out collaborative projects to better understand the burden of NASH/MASH across the world. The Global NASH Council has been endorsed by a number of organizations. For more details, please see our Mission, Vision and Values.
About UsThe Global NASH Council™
(GNC)
The Global NASH Council has been formed to bring together international experts to discuss, collaborate and contribute to the field of MASH/NASH. Given the global nature of MASLD, it is important to include perspectives from different regions of the world, assess the clinical and economic impact of these liver diseases based on the realities of each country and region. The Global NASH Council meets in person as well as via several Web-meetings each year. The in-person meetings are designed to discuss new topics in the field and design joint projects that will contribute to the understanding of this important liver disease. Most members of the Councils are also active participating sites for the the Global NASH Registry ™.
Learn More
The Global NASH and Liver Registries
The Global NASH Registry™ and The Global Liver Registry™ are collaborative efforts led by members of the Global NASH Council and the Global Liver Council. These Registries are developed to collect clinical data, laboratory data and PRO data for patients with NASH/MASH, HBV, HCV, HDV, PBC and ALD from different regions of the world. Inclusion into these Registries requires collection of the data after informed consent. Data is entered through secure cloud platform into a central secured database managed by CORLD. The information in the Registries is completely de-identified and HIPAA compliant. These Registries include sites from North America, Europe, Asia, Middle East, North Africa and Australia, with new sites starting in Latin America and Africa. The ultimate goals of these registries are to obtain real world clinical and PRO data about patients with the most common causes of liver disease from different regions of the world. This data will inform us about the similarities and differences of these important liver diseases across the globe.
Learn More